ArticleJournal of gastrointestinal oncology2026
Perioperative clinicopathologic model for predicting 12-month early recurrence after curative hepatectomy in hepatocellular carcinoma.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic burden but not metabolic dysfunction-associated steatotic liver disease affects the prognosis of patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early recurrence (ER) within 12 months after curative hepatectomy remains a major determinant of poor survival in patients with hepatocellular carcinoma (HCC). Identifying high-risk patients using routinely available perioperative parameters may enable more tailored postoperative surveillance. This study aimed to develop and validate a machine-learning model based on clinical and laboratory variables to predict 12-month ER after resection. Methods: This retrospective study included 100 consecutive patients who underwent curative-intent hepatectomy for pathologically confirmed HCC. Perioperative demographic, clinical, laboratory, and tumor-related variables were collected. A logistic regression model with L1 regularization was constructed. No missing values were observed among candidate predictors or outcome variables; therefore, all eligible patients were included in the final analysis without imputation. Continuous variables were standardized using z-score normalization, and categorical variables were transformed through one-hot encoding. Given the limited number of outcome events (n=40), penalized regression was applied to restrict model complexity and reduce the risk of overfitting. Model performance was evaluated using repeated stratified five-fold cross-validation (5×5 repetitions), and all performance metrics were calculated from out-of-fold predictions. Discrimination, calibration, and clinical utility were assessed using the area under the receiver operating characteristic curve (AUC), the area under the precision-recall curve (AUPRC), Brier score, calibration intercept and slope, and decision curve analysis (DCA). Results: Forty patients (40.0%) developed ER. Significant predictors of ER included diabetes mellitus (P=0.02), capsular invasion (P=0.02), multiple tumors (P=0.001), and lower total bilirubin levels (P=0.03). Edmondson-Steiner grade ≥3 was more frequent in the ER group but did not reach statistical significance (40.0% Conclusions: A machine-learning model based on routinely available perioperative clinicopathologic variables demonstrated favorable internally validated performance in predicting 12-month ER after curative hepatectomy for HCC. This accessible and practical tool may assist in postoperative risk stratification and individualized surveillance planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.